Thiazolidinediones

DRUG6 trials

Sponsors

Canadian Network for Observational Drug Effect Studies, CNODES, Novo Nordisk A/S, Sanofi, Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders

Conditions

DiabetesDiabetes Mellitus, Type 2Type 2 Diabetes MellitusType2diabetes

Phase 4

Efficacy in Controlling Glycaemia With Victoza® (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 Diabetes

CompletedNCT02730377

Novo Nordisk A/SDiabetes, Diabetes Mellitus, Type 2

Start: 2016-03-28End: 2019-08-12Updated: 2020-07-07

A Study to Evaluate the Effectiveness and Safety Initiation and Titration of Insulin Glargine (U300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus (T2DM) Controlled on Oral Antidiabetic Drug Treatment in Turkey

CompletedNCT02954692

SanofiType 2 Diabetes Mellitus

Start: 2016-11-30End: 2017-12-22Updated: 2019-01-14

Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh

Not yet recruitingNCT06449235

Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic DisordersType2diabetes

Start: 2024-09-30End: 2025-06-30Target: 938Updated: 2024-07-16

Unknown Phase

Incretin-based Drugs and the Risk of Heart Failure

CompletedNCT02456428

Canadian Network for Observational Drug Effect Studies, CNODESType 2 Diabetes Mellitus

Start: 2014-03-31End: 2015-05-31Updated: 2016-04-19

Incretin-based Drugs and Pancreatic Cancer

CompletedNCT02475499

Canadian Network for Observational Drug Effect Studies, CNODESDiabetes Mellitus, Type 2

Start: 2014-03-31End: 2015-04-30Updated: 2016-03-14

Incretin-based Drugs and Acute Pancreatitis

CompletedNCT02476760

Canadian Network for Observational Drug Effect Studies, CNODESDiabetes Mellitus, Type 2

Start: 2014-03-31End: 2015-04-30Updated: 2016-11-03

Related Papers

Maintenance of glycaemic control with liraglutide versus oral antidiabetic drugs as add‐on therapies in patients with type 2 diabetes uncontrolled with metformin alone: A randomized clinical trial in primary care ( <scp>LIRA‐PRIME</scp> )

Diabetes Obesity and Metabolism2021-10-0914 citations

922-P: LIRA-PRIME: A Randomized Trial in Primary Care Settings of Liraglutide vs. OAD for Glycemic Control in Patients with Type 2 Diabetes Not in Control on Metformin

Diabetes2020-06-011 citations

LIRA-PRIME Trial Design and Baseline Data—Efficacy in Controlling Glycemia with Liraglutide in a Primary Care Setting

Diabetes2018-06-22

A Multicenter Observational Study of Incretin-based Drugs and Heart Failure

New England Journal of Medicine2016-03-23220 citations